Skip to main content

Published locations for Adding cisplatin to docetaxel monotherapy provides no benefit for elderly with NSCLC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Adding cisplatin to docetaxel monotherapy provides no benefit for elderly with NSCLC

User login

  • Reset your password
  • /content/adding-cisplatin-docetaxel-monotherapy-provides-no-benefit-elderly-nsclc
  • /acssurgerynews/article/96359/lung-cancer/adding-cisplatin-docetaxel-monotherapy-provides-no-benefit
  • /oncologypractice/article/96359/lung-cancer/adding-cisplatin-docetaxel-monotherapy-provides-no
  • /hematology-oncology/article/96359/lung-cancer/adding-cisplatin-docetaxel-monotherapy-provides-no
  • /surgery/article/96359/lung-cancer/adding-cisplatin-docetaxel-monotherapy-provides-no-benefit-elderly
  • /chestphysician/article/96359/lung-cancer/adding-cisplatin-docetaxel-monotherapy-provides-no-benefit